NeuroPace (NPCE): High Growth Forecast and Path to Profitability Reinforce Bullish Narratives [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
Revenue is projected to climb at a strong 14.9% per year, exceeding the US market average of 10.5%. Losses have narrowed by 2.2% per year over the past five years. Investors are likely to focus on these aggressive growth forecasts and the potential for upside, given analyst estimates put the current share price of $12.98 below some fair value targets. See our full analysis for NeuroPace. Next, we'll see how these results measure up against the prevailing narratives from the broader market and the community at Simply Wall St. Sometimes these perspectives reinforce the story, while at other times they provide a different viewpoint. See what the community is saying about NeuroPace NasdaqGM:NPCE Earnings & Revenue History as at Nov 2025 Potential Margin Expansion Hinges on Product Mix NeuroPace's gross margins could come under pressure if distributed products (such as DIXI Medical lines) continue to account for a larger proportion of sales, since these have lower margins compa
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual MeetingBusiness Wire
- NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient ServicesBusiness Wire
- NeuroPace (NPCE) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NASDAQ:NPCE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 11/4/25 - Beat
NPCE
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form 4
- 12/1/25 - Form 4
- NPCE's page on the SEC website